Skip to NavigationSkip to content

Pharmafile - News News

The release of Women Count 2019, an annual report funded by The Pipeline, has revealed that “little to no progress” has been made in pushing for...
MSD has announced the approval from the FDA of its combination therapy Recarbrio (imipenem, cilastatin and relebactam) in the treatment of adult...
Vas Narasimhan, Novartis’ CEO, has set aside $700 million to settle a bribery lawsuit in the United States.
The UN health organisation has declared a global public health emergency over the Ebola outbreak, after an emergency committee meeting in Geneva.
The largest art gallery in the world has taken down all mentions of the Sackler family which include a plaque acknowledging their donations and...
A humanitarian consortium has successfully completed a testing programme for the delivery of temperature-controlled medicines via the use of...
Novartis’ Kisqali (ribociclib) has secured recommendation from NICE in combination with fulvestrant, meaning the cyclin-dependent kinase 4 and 6 (...
Roche’s Genentech unit has signed a deal with Massachusetts-based firm Skyhawk Therapeutics to develop and commercialise small molecules that...
Roche’s Genentech has entered into a partnership with Sosei Heptares to develop small molecules and biologics that G protein-coupled receptor (GPCR...
AstraZeneca has revealed plans to use only electric vehicles by 2030.
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches